Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLOMAX in Acute Urinary Retention due to BPH
NCT02244294Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2001
- Primary completion
- Jun 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tamsulosin in acute urinary retention, sponsored by Boehringer Ingelheim. Started Mar 2001; status: completed.
02
Drugs
tamsulosin
03
Conditions
acute urinary retention
Beyond the preview
Go deeper on NCT02244294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02244294.